Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - VistaGen Therapeutics, Inc. | vtgn10k_mar312020.htm |
| EX-31.2 - CERTIFICATION - VistaGen Therapeutics, Inc. | ex-312.htm |
| EX-31.1 - CERTIFICATION - VistaGen Therapeutics, Inc. | ex-311.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - VistaGen Therapeutics, Inc. | ex-231.htm |
EXHIBIT 32
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18
U.S.C. § 1350, as created by Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned officer of VistaGen
Therapeutics, Inc. (the “Company ”) hereby certifies, to
such officer’s knowledge, that:
(i) the
accompanying Annual Report on Form 10-K of the Company for the
annual period ended March 31, 2020 (the “Report”) fully complies with the
requirements of Section 13(a) or Section 15(d), as
applicable, of the Securities Exchange Act of 1934, as amended;
and
(ii)
the information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
June 29, 2020
/s/ Shawn K. Singh
Shawn
K. Singh, JD
Principal
Executive Officer
/s/ Jerrold D. Dotson
Jerrold
D. Dotson
Principal
Financial Officer